KoBioLabs, Inc (KOSDAQ:348150)
South Korea
· Delayed Price · Currency is KRW 4,420.00
-250.00 (-5.35%)
At close: Mar 9, 2026
KoBioLabs Revenue
KoBioLabs had revenue of 19.26B KRW in the quarter ending September 30, 2025, with 13.88% growth. This brings the company's revenue in the last twelve months to 71.83B, up 17.19% year-over-year. In the year 2024, KoBioLabs had annual revenue of 68.36B with 106.28% growth.
Revenue (ttm)
71.83B
Revenue Growth
+17.19%
P/S Ratio
1.19
Revenue / Employee
n/a
Employees
n/a
Market Cap
85.83B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Choong Ang Vaccine Laboratory | 39.19B |
| Naturalendo Tech | 21.87B |
| CTCBIO | 132.76B |
| Cell Biotech | 50.65B |
| Parataxis Korea | 10.10M |
| Shaperon | 179.38M |
| Quratis | 2.28B |
| Progen | 450.00M |